Quick Answer
HCW Biologics Inc. reported Stockholders Equity of $2.76 million for fiscal year 2025.
HCW Biologics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.76M | +140.8% |
| 2024 | -$6.77M | -150.3% |
| 2023 | $13.46M | -64.0% |
| 2022 | $37.43M | -26.9% |
| 2021 | $51.19M | +406.2% |
| 2020 | -$16.72M | -72.8% |
| 2019 | -$9.68M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.11M | +78.9% | -3954.5% |
| June 30, 2025 | -$52.0K | +99.2% | +99.4% |
| March 31, 2025 | -$8.56M | -198.0% | -26.5% |
| December 31, 2024 | -$6.77M | -150.3% | +32.1% |
| September 30, 2024 | -$9.97M | -141.8% | -58.3% |
| June 30, 2024 | -$6.30M | -122.0% | -172.1% |
| March 31, 2024 | $8.74M | -73.2% | -35.1% |
| December 31, 2023 | $13.46M | -64.0% | -43.6% |
- HCW Biologics Inc. showed an increase of +140.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, HCW Biologics Inc.’s stockholders equity has grown by 128.6% (from -$9.68 million to $2.76 million).
- The most recent figure is from HCW Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: